AIM ImmunotechIV PembrolizumabcisplatinRintatolimodMerckEpithelial ovarian cancerEOC
…cknowledgements This trial receives support from both Merck and AIM Immunotech.References Heintz AP, et al. Carcinoma of the ovary. FIGO 26th …
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: AIM Immunotech ×
AIM Immunotech
This institution is selected. Its supporting articles are shown below.